Akzo Nobel NV, Dendreon deal

AKZOY's Diosynth Biotechnology unit, which manufactures antigen for DNDN's Provenge prostate cancer vaccine, purchased $3.5 million worth of DNDN stock. The companies also expanded the scope of thei...